Literature DB >> 200247

Adjuvant polyarthritis. III. Evidence in support of viral etiology.

Y H Chang, W Hoffman.   

Abstract

Intraperitoneal administration of a relatively small volume (0.2 ml) of plasma obtained from Sindbis virus--infected animals containing approximately 480 units of interferon/ml effectively suppressed the development of adjuvant arthritis. Similarly, administration of interferon (624 units/rat/day, ip) prepared in vitro by exposing rat embryo fibroblast culture to poly I:C in the presence of cycloheximide also suppressed the development of adjuvant arthritis without affecting the humoral or the cell-mediated immune response. The findings provide circumstantial evidence to the speculation that a virus or a virus-like organism plays a role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 200247     DOI: 10.1002/art.1780200810

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  5 in total

1.  Adjuvant-induced arthritis in rats. Evidence that autoimmunity to homologous collagens types I, II, IX and XI is not involved in the pathogenesis of arthritis.

Authors:  M A Cremer; A S Townes; A H Kang
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Arthritis-inducing ability of a synthetic adjuvant, N-acetylmuramyl peptides, and bacterial disaccharide peptides related to different oil vehicles and their composition.

Authors:  O Kohashi; A Tanaka; S Kotani; T Shiba; S Kusumoto; K Yokogawa; S Kawata; A Ozawa
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

Review 3.  Adjuvant polyarthritis in rats: is this a satisfactory model for screening anti-arthritic drugs?

Authors:  K D Rainsford
Journal:  Agents Actions       Date:  1982-10

4.  The absence of antibodies to type II collagen in established adjuvant arthritis in rats.

Authors:  F DeLustro; R P Carlson; L J Datko; B DeLustro; A J Lewis
Journal:  Agents Actions       Date:  1984-06

5.  Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.

Authors:  Y H Chang; C M Pearson; L Chedid
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.